64
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Survival and prognostic factors in adult medulloblastoma: the Salah Azaiz Institute experience

ORCID Icon, , , , , , & show all
Pages 472-475 | Received 22 Apr 2020, Accepted 22 Feb 2021, Published online: 10 Mar 2021

References

  • Quinlan A, Rizzolo D. Understanding medulloblastoma. JAAPA 2017;30:30–36.
  • Riffaud L, Hénaux P-L. [Prognostic factors of adult medulloblastomas: a review of the literature and perspectives]. Neurochirurgie 2016;62:46–52.
  • Bloom HJ, Bessell EM. Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 1990;18:763–72.
  • Vigneron C, Antoni D, Coca A, et al. Médulloblastomes de l’adulte: étude rétrospective portant sur [Adult medulloblastoma: retrospective series of 21 patients]. Cancer Radiother 2016;20:14–17.
  • Buglione M, Ghirardelli P, Triggiani L, et al. Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program. Rep Pract Oncol Radiother 2015;20:284–91.
  • Thomas PR, Deutsch M, Kepner JL, et al. Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 2000;18:3004–11.
  • Padovani L, Sunyach M-P, Perol D, et al. Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 2007;68:433–40.
  • Call JA, Naik M, Rodriguez FJ, et al. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma. Am J Clin Oncol 2014;37:1–7.
  • Riffaud L, Saikali S, Leray E, et al. Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 2009;111:478–87.
  • Kann BH, Lester-Coll NH, Park HS, et al. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Neuro-Oncol 2017;19:259–69.
  • Franceschi E, Bartolotti M, Paccapelo A, et al. Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? J Neurooncol 2016;128:235–40.
  • Moots PL, O'Neill A, Londer H, et al. Preradiation chemotherapy for adult high-risk medulloblastoma: a trial of the ECOG-ACRIN Cancer Research Group (E4397). Am J Clin Oncol 2018;41:588–94.
  • Taillandier L, Blonski M, Carrie C, et al. Medulloblastomas: review. Rev Neurol 2011;167:431–48.
  • Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995;25:166–78.
  • Back M, Ahern V, Berry M, et al. Importance of radiation time and dose factors on outcome for childhood medulloblastoma. Australas Radiol 2005;49:298–303.
  • Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A. Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2002;54:855–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.